Document is current

Article History

Received: 7 February 2018

Accepted: 13 June 2018

First Online: 19 June 2018

Ethics approval and consent to participate

: This is a dosimetric sub-study from a prospective multicentric randomized phase-II trial (ExternalRef removed Identifier NCT01764646). The trial obtained the ethics approval from Geneva Univeristy Hospital Protocole 11–196 (NAC 11–089).

: We obtained written informed consent to publish from patients.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.